We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+17.41%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$5.17B
AUM Growth
+$204M
(+4.1%)
Cap. Flow
-$539M
Cap. Flow
% of AUM
-10.44%
Top 10 Holdings %
Top 10 Hldgs %
26.55%
Holding
192
New
25
Increased
43
Reduced
107
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$26.3M |
| 2 |
Alibaba
BABA
|
+$25.3M |
| 3 |
Abbott
ABT
|
+$12.9M |
| 4 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$12.5M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$40.1M |
| 2 |
PPLI
People Inc
PPLI
|
+$37.7M |
| 3 |
AbbVie
ABBV
|
+$37.7M |
| 4 |
MasTec
MTZ
|
+$30.4M |
| 5 |
Pool Corp
POOL
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.37% |
| 2 | Healthcare | 18.43% |
| 3 | Technology | 14.97% |
| 4 | Financials | 13.64% |
| 5 | Industrials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Neurocrine Biosciences
NBIX
$15.9B
| $18.2M | 0.35% |
207,000
+6,600
| +3% | +$552K |
|
|
NBIS
77
Nebius Group N.V.
NBIS
$70.5B
| $17.4M | 0.34% |
506,406
-30,000
| -6% | -$995K |
|
78
Intuit
INTU
$91.6B
| $17.3M | 0.34% |
66,350
-45,500
| -41% | -$10.5M |
|
79
Rockwell Automation
ROK
$50.1B
| $17M | 0.33% |
97,000
-5,000
| -5% | -$850K |
|
|
AMTD
80
DELISTED
TD Ameritrade Holding Corp
AMTD
| $16.6M | 0.32% |
332,500
-27,500
| -8% | -$1.49M |
|
81
Western Alliance Bancorporation
WAL
$9.01B
| $16M | 0.31% |
390,000
-363,842
| -48% | -$16M |
|
82
Meta Platforms (Facebook)
META
$1.47T
| $15.7M | 0.3% |
94,310
-25,690
| -21% | -$4.09M |
|
|
ANSS
83
DELISTED
Ansys
ANSS
| $15.5M | 0.3% |
84,800
-2,355
| -3% | -$398K |
|
84
American Express
AXP
$232B
| $15.4M | 0.3% |
141,100
-2,900
| -2% | -$305K |
|
85
Trupanion
TRUP
$1.33B
| $15.4M | 0.3% |
470,000
-190,000
| -29% | -$5.41M |
|
|
TVTY
86
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $14.9M | 0.29% |
850,000
+557,428
| +191% | +$11.9M |
|
87
Rollins
ROL
$17.6B
| $14.6M | 0.28% |
525,000
-182,385
| -26% | -$4.74M |
|
88
Starbucks
SBUX
$124B
| $14.6M | 0.28% |
195,790
-4,210
| -2% | -$289K |
|
89
Baxter International
BAX
$13.9B
| $14.5M | 0.28% |
177,800
+15,000
| +9% | +$1.09M |
|
|
KYNB
90
Kyntra Bio
KYNB
$28.7M
| $14.5M | 0.28% |
10,640
-3,256
| -23% | -$4.42M |
|
91
Ormat Technologies
ORA
$6.97B
| $14.2M | 0.27% |
256,994
-18,619
| -7% | -$1.03M |
|
92
First Horizon
FHN
$12.3B
| $14M | 0.27% |
1,000,000
-390,000
| -28% | -$5.76M |
|
|
EXAS
93
DELISTED
Exact Sciences
EXAS
| $13.9M | 0.27% |
160,000
-59,100
| -27% | -$5.03M |
|
94
SolarEdge
SEDG
$1.97B
| $13.8M | 0.27% |
366,097
-7,562
| -2% | -$302K |
|
95
Vertex Pharmaceuticals
VRTX
$133B
| $13.6M | 0.26% |
74,000
-15,000
| -17% | -$2.77M |
|
96
Credicorp
BAP
$29.6B
| $13.6M | 0.26% |
56,665
| – | – |
|
97
Sensient Technologies
SXT
$5.55B
| $13.6M | 0.26% |
200,000
-350,000
| -64% | -$22M |
|
98
TJX Companies
TJX
$169B
| $13.5M | 0.26% |
254,349
-18,066
| -7% | -$901K |
|
99
First Solar
FSLR
$24.4B
| $13.5M | 0.26% |
255,962
+3,771
| +1% | +$190K |
|
100
Teladoc Health
TDOC
$1.22B
| $13.4M | 0.26% |
241,639
-30,775
| -11% | -$1.88M |
|
Similar funds
VIA
Handelsbanken Fonder's Q1 2019 Portfolio in Review
As of Q1 2019, Handelsbanken Fonder held 192 positions worth $5.17B, up 4.1% from $4.96B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Handelsbanken Fonder withdrew a net $539M in Q1 2019, closing 10 positions and reducing 107 holdings. Its most notable exit was Cinemark Holdings, an estimated $20.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Handelsbanken Fonder opened a new position in Boingo Wireless, Inc. worth $12.8M.
- Handelsbanken Fonder's largest Q1 2019 buy was Boingo Wireless, Inc.: 550,000 shares worth $12.8M.
- Handelsbanken Fonder added most to Eli Lilly in Q1 2019, an estimated $26.3M increase.
- Handelsbanken Fonder's biggest Q1 2019 reduction was Johnson & Johnson, cutting an estimated $40.1M.
- Handelsbanken Fonder fully exited Cinemark Holdings in Q1 2019, selling an estimated $20.4M.
- Handelsbanken Fonder's ten largest holdings make up 27% of its $5.17B portfolio in Q1 2019.
- Handelsbanken Fonder opened 25 new positions and closed 10 in Q1 2019.
- Handelsbanken Fonder's portfolio value rose 4.1% quarter-over-quarter to $5.17B.
Based on Handelsbanken Fonder's 13F filing for Q1 2019, filed 10 May 2019.